Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.08%.

  • Utah Medical Products' Return on Invested Capital fell 200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.02% for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Utah Medical Products reported Return on Invested Capital of 0.08% as of Q3 2025, which was down 200.0% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Utah Medical Products' Return on Invested Capital peaked at 0.15% during Q3 2022, and registered a low of 0.08% during Q3 2025.
  • For the 5-year period, Utah Medical Products' Return on Invested Capital averaged around 0.12%, with its median value being 0.12% (2023).
  • Per our database at Business Quant, Utah Medical Products' Return on Invested Capital plummeted by -400bps in 2021 and then surged by 400bps in 2022.
  • Over the past 5 years, Utah Medical Products' Return on Invested Capital (Quarter) stood at 0.13% in 2021, then rose by 2bps to 0.14% in 2022, then decreased by -20bps to 0.11% in 2023, then dropped by -16bps to 0.09% in 2024, then dropped by -14bps to 0.08% in 2025.
  • Its Return on Invested Capital stands at 0.08% for Q3 2025, versus 0.09% for Q2 2025 and 0.09% for Q1 2025.